Report
Michael B. Schäfer

Wacker Chemie AG : Q1 EBITDA 8% above cons, EBITDA now seen at upper end (€ 1.5bn, in-line with cons), revised segments point to € 1.6bn

>Q1 EBITDA came in 8% ahead of the consensus on strong chemicals - Q1 EBITDA came in 8% ahead of consensus, gaining 161% y-o-y (+€ 397m) to € 644m (cons/ODDO: € 596m/€ 602m) from € 246m a year ago. Key elements were largely flagged at the Q4 conference call already but chemicals EBITDA came in better than expected. Group sales gained 53% y-o-y or € 717m to € 2,076m, accelerating from 36% y-o-y in Q4 2021 on continuing pricing initiatives contributing 43pp and 6pp from...
Underlying
Wacker Chemie AG

Wacker Chemie is active in chemical products. Co. operates in five divisions: Wacker Silicones, which provides products ranging from silicone fluids and emulsions, resins, elastomers and sealants, to silanes and pyrogenic silica grades; Wacker Polymers, which manufactures binders and polymeric additives (such as dispersible polymer powders and dispersions); Wacker Biosolutions, which supplies customized biotech and catalog products for the fine-chemical sector; Wacker Polysilicon, which produces hyperpure polysilicon for the semiconductor, electronics and above all, solar sectors; and Siltronic, which supplies semiconductor manufacturers with silicon wafers.

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Michael B. Schäfer

ResearchPool Subscriptions

Get the most out of your insights

Get in touch